Liensinine Promotes Apoptosis in Rheumatoid Arthritis Fibroblast-Like Synoviocytes via p38 MAPK-Mediated Mitochondrial Pathway: An In Vitro Multi-Omics and Functional Validation Study
DNA and Cell Biology · 01.12.2026 · 45 (12) · 576-590
DOI: 10.1177/10445498261487191 ↗Kurz gefasst
Fachartikel in der Zeitschrift DNA and Cell Biology, online erschienen am 22.09.2026. Verfasst von Shoudi He und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine and Allergy, The Third Affiliated Hospital (The Affiliated Luohu Hospital) of Shenzhen University, Shenzhen, China. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Science and Technology Planning Project of Guangdong Province, Guangdong Medical Association Clinical Research Special Fund, Hunan Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by synovial inflammation and joint destruction. Oxidative stress has been implicated in its pathogenesis. This in vitro study aimed to investigate the effects of liensinine (LIE) on the apoptosis of fibroblast-like synoviocytes (FLSs) and its underlying mechanisms. RA-FLSs were isolated from patients and cultured in low-glucose Dulbecco's Modified Eagle Medium (DMEM). Following LIE treatment, cell viability was assessed using the cell-counting kit-8 assay, and lactate dehydrogenase (LDH) release was measured to evaluate cytotoxicity. Apoptosis was assessed by 4′,6-diamidino-2-phenylindole (DAPI) staining and flow cytometry. Oxidative stress was evaluated by reactive oxygen species (ROS) production and mitochondrial membrane potential using 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide (JC-1) staining. Caspase-3/7 activity was measured using the Caspase-Glo ® 3/7 luminescent assay (Promega) following the manufacturer’s instructions. RNA sequencing and network pharmacology analysis were performed to identify differentially expressed genes and signaling pathways affected by LIE. Western blotting was used to analyze key proteins in the mitogen-activated protein kinase (MAPK) and apoptosis pathways. Molecular docking and dynamics simulations evaluated LIE binding to P38 and Caspase9. LIE significantly reduced cell viability and increased LDH release in RA-FLSs in a dose-dependent manner. LIE induced apoptosis and elevated oxidative stress, evidenced by increased ROS and altered mitochondrial membrane potential. RNA sequencing and network pharmacology revealed significant changes in genes related to MAPK and apoptosis signaling. Western blot confirmed activation of p38 MAPK and caspase-3/9, suggesting LIE-induced apoptosis correlates with oxidative stress and MAPK pathway activation. LIE exhibited strong binding affinities to P38 and Caspase9, with favorable stability in dynamics simulations. These in vitro findings suggest that LIE has therapeutic potential for RA by targeting MAPK and apoptosis pathways in RA-FLSs, warranting further in vivo validation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine and Allergy, The Third Affiliated Hospital (The Affiliated Luohu Hospital) of Shenzhen University, Shenzhen, China.
- State Key Laboratory of Respiratory Disease Shenzhen University Division, Shenzhen University Medical School, Shenzhen University, Shenzhen, China.
- Institute of Allergy and Immunology, Shenzhen Key Laboratory of Allergy and Immunology, Guangdong Engineering Technology Research Center for Allergen Standardization, Shenzhen University, Shenzhen, China.
- School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-Sen University, Shenzhen, China.
- Department of Rheumatology and Immunology, People's Hospital of Ningxiang City, Ningxiang, China.
- Department of Traditional Chinese Medicine Rheumatology, Nanshan District People's Hospital, Shenzhen, China.
ORCID-Profile: Shoudi He
Förderung
- Science and Technology Planning Project of Guangdong Province
- Guangdong Medical Association Clinical Research Special Fund
- Hunan Provincial Natural Science Foundation of China
- This research was supported by Shenzhen Medical Research Fund
- National Natural Science Foundation of China
Zitieren
APA
He, S., Peng, M., Wei, J., Cai, H., Dai, Z., Tan, N., Peng, L., Yang, Z., Xu, D., Li, J., Zhao, W., & Xiao, X. (2026). Liensinine Promotes Apoptosis in Rheumatoid Arthritis Fibroblast-Like Synoviocytes via p38 MAPK-Mediated Mitochondrial Pathway: An In Vitro Multi-Omics and Functional Validation Study. DNA and Cell Biology, 45(12), 576-590. https://doi.org/10.1177/10445498261487191
Vancouver
He S, Peng M, Wei J, Cai H, Dai Z, Tan N, et al. Liensinine Promotes Apoptosis in Rheumatoid Arthritis Fibroblast-Like Synoviocytes via p38 MAPK-Mediated Mitochondrial Pathway: An In Vitro Multi-Omics and Functional Validation Study. DNA and Cell Biology. 2026;45(12):576-590. doi:10.1177/10445498261487191
BibTeX
@article{He2026,
author = {He, Shoudi and Peng, Mian and Wei, Juntong and Cai, Hui and Dai, Zongshun and Tan, Ning and Peng, Liping and Yang, Zhaowei and Xu, Damo and Li, Jing and Zhao, Wen and Xiao, Xiaojun},
title = {Liensinine Promotes Apoptosis in Rheumatoid Arthritis Fibroblast-Like Synoviocytes via p38 MAPK-Mediated Mitochondrial Pathway: An In Vitro Multi-Omics and Functional Validation Study},
journal = {DNA and Cell Biology},
year = {2026},
volume = {45},
number = {12},
pages = {576--590},
doi = {10.1177/10445498261487191}
}
EUVIMED